ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ACAD Acadia Pharmaceuticals Inc

17.07
0.00 (0.00%)
Pre Market
Last Updated: 07:00:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 16.10
Ask Price 18.00
News -
Day High

Low
16.765

52 Week Range

High
33.99

Day Low
Company Name Stock Ticker Symbol Market Type
Acadia Pharmaceuticals Inc ACAD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 17.07 07:00:00
Open Price Low Price High Price Close Price Prev Close
17.07
Trades Volume Avg Volume 52 Week Range
0 0 - 16.765 - 33.99
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 17.07 USD

Acadia Pharmaceuticals (ACAD) Options Flow Summary

Overall Flow

Bearish

Net Premium

-10M

Calls / Puts

0.00%

Buys / Sells

112.50%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Acadia Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.81B 164.77M - 726.44M -61.29M -0.37 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Acadia Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ACAD Message Board. Create One! See More Posts on ACAD Message Board See More Message Board Posts

Historical ACAD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week17.4017.61516.76517.071,074,377-0.33-1.90%
1 Month18.3518.6316.76517.811,346,968-1.28-6.98%
3 Months27.1827.9416.76521.821,783,431-10.11-37.20%
6 Months23.3632.5916.76524.081,767,435-6.29-26.93%
1 Year19.6433.9916.76524.761,687,230-2.57-13.09%
3 Years21.044533.9912.2421.191,669,357-3.97-18.89%
5 Years23.7458.7212.2427.991,609,705-6.67-28.10%

Acadia Pharmaceuticals Description

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Your Recent History

Delayed Upgrade Clock